Hikma to take control of Algerian joint venture
Hikma is to take full control of its Algerian joint venture in an $18.5m (€13.6m) deal, continuing its expansion in the region.
Hikma is to take full control of its Algerian joint venture in an $18.5m (€13.6m) deal, continuing its expansion in the region.
DiscoveRx has added GPCR platforms to its portfolio, enhancing its ability to provide information on a compound’s mode of action, activated receptor recycling and efficacy in animal models.